<DOC>
	<DOC>NCT02396225</DOC>
	<brief_summary>Concentrations of voriconazole in pulmonary epithelial lining fluid and in serum are compared after inhalation of 40 mg voriconazole b.i.d. for two days or oral intake of voriconazole tablets 400 mg bid for 1 day followed by 200 mg b.i.d. for one day, respectively.</brief_summary>
	<brief_title>Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Planned bronchoscopy in relation to workup after hemoptysis or other symptom leading to bronchoscopy Informed written consent Performance status 01 Ct scan of thorax without suspicion of malignancy Weight t ≥ 60 og ≤ 130 kg Male gender or female gender in postmenopausal state defined by amenorrhea in more than 12 months. Voriconazole treatment up to one week before inclusion Secreatinin≥ 100 uM ALAT ≥ 70 U/l QTinterval &gt; 480 ms Allergic reaction to voriconazole or constituents in Vfend Allergic reaction to other azoles Ischemic Heart disease, Heart failure or uncontrolled hypertension Treatment with statins or omeprazole, which cannot be paused for three days during voriconazole exposure Treatment with Efavirenz, rifabutin, ritonavir, everolimus, methadon, alfentanil, fentanyl, sufentanil, oxycodone, hydrocodone, fluconazole, aztemizol, cisaprid, pimozid, quinidine, terfenadine, carbamazepine, phenobarbital, mephobarbital, ergotamine, dihydroergotamine, rifampicine, st. johns worth, everolimus, phenytoin, warfarin, phenprocoumon, acenocoumarol, benzodiazepines as midazolam, triazolam, alprazolam, sirolimus, cyclosporine, tacrolimus, ibuprofen, diclofenac,tolbutamide, glipizide, vincristine, vinblastine or other vinca alkaloids, HIVprotease Inhibitors e.g. saquinavir, amprenavir and nelfinavir, delavirdine, nivrapine and other nonnocleaoside revers transcriptase inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>voriconazole</keyword>
	<keyword>inhalation</keyword>
	<keyword>aerosol</keyword>
	<keyword>epithelial lining fluid</keyword>
	<keyword>concentration</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>